Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
• NP718249.RAReI_uoScLx6SKiyJKz5LuRVbB1YRAilRY84DChegWL0130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718249.RAReI_uoScLx6SKiyJKz5LuRVbB1YRAilRY84DChegWL0130_provenance.
• NP718252.RAVt_v6lUjPp7BhSx9aYLUg3jt0oPv4uHLwmMZ1lYaLa4130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718252.RAVt_v6lUjPp7BhSx9aYLUg3jt0oPv4uHLwmMZ1lYaLa4130_provenance.
• NP718253.RAQJgju5KWRKgq7M0T3SBUrjh5uESYJACZpRw86roQvf4130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718253.RAQJgju5KWRKgq7M0T3SBUrjh5uESYJACZpRw86roQvf4130_provenance.
• NP718254.RAd0cQX-9MmPGH4If0_9Luk_IPhLD-TOgtlBYJT50oCKA130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718254.RAd0cQX-9MmPGH4If0_9Luk_IPhLD-TOgtlBYJT50oCKA130_provenance.
• NP718247.RAvyXiOmcfN1bOZPRVg-jFyoSOT5p9sgAXoLVEfK_Ep8s130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718247.RAvyXiOmcfN1bOZPRVg-jFyoSOT5p9sgAXoLVEfK_Ep8s130_provenance.
• NP718248.RAgTUtEZznWWunlfQ0YrGL6M0F-4NoQTNL8AyZvyzQQbQ130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718248.RAgTUtEZznWWunlfQ0YrGL6M0F-4NoQTNL8AyZvyzQQbQ130_provenance.
• NP718251.RALiGDjFYKf5APLuEP_WI9XXMjbG-6yYjRjaCmgPi8i4M130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718251.RALiGDjFYKf5APLuEP_WI9XXMjbG-6yYjRjaCmgPi8i4M130_provenance.
• NP718250.RA_ep5gHaS70nXcBRob-USeK2OS7NBZKMbB3Qua0wmIQQ130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718250.RA_ep5gHaS70nXcBRob-USeK2OS7NBZKMbB3Qua0wmIQQ130_provenance.
• NP718256.RA0S1R6XMP1g61tbQXmGTBUoL45Tl7UWm95ujcSZsqgao130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718256.RA0S1R6XMP1g61tbQXmGTBUoL45Tl7UWm95ujcSZsqgao130_provenance.